Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bromocriptine | 5 | 2022 | 93 | 1.770 |
Why?
|
Dopamine Agonists | 4 | 2017 | 353 | 1.420 |
Why?
|
Metformin | 6 | 2018 | 914 | 0.820 |
Why?
|
Diet, Sodium-Restricted | 4 | 2012 | 291 | 0.670 |
Why?
|
Hypoglycemic Agents | 6 | 2017 | 3111 | 0.640 |
Why?
|
Sodium Chloride, Dietary | 4 | 2013 | 294 | 0.490 |
Why?
|
Parathyroid Neoplasms | 2 | 2011 | 244 | 0.420 |
Why?
|
Diabetes Mellitus, Type 2 | 9 | 2022 | 12242 | 0.420 |
Why?
|
Renin-Angiotensin System | 3 | 2012 | 735 | 0.410 |
Why?
|
Hypertension | 9 | 2013 | 8610 | 0.390 |
Why?
|
Hyperglycemia | 3 | 2015 | 1389 | 0.390 |
Why?
|
Angiotensin II | 2 | 2011 | 849 | 0.360 |
Why?
|
Renin | 5 | 2012 | 642 | 0.330 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2011 | 164 | 0.320 |
Why?
|
Insulin | 6 | 2017 | 6606 | 0.310 |
Why?
|
Sodium, Dietary | 3 | 2012 | 427 | 0.310 |
Why?
|
Glipizide | 3 | 2018 | 48 | 0.300 |
Why?
|
Hypopituitarism | 1 | 2010 | 251 | 0.290 |
Why?
|
Pancreatitis | 2 | 2011 | 1087 | 0.290 |
Why?
|
Prediabetic State | 1 | 2013 | 548 | 0.290 |
Why?
|
Interleukin-6 | 2 | 2011 | 3234 | 0.230 |
Why?
|
Adenoma | 2 | 2011 | 2163 | 0.220 |
Why?
|
Blood Glucose | 10 | 2018 | 6429 | 0.210 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15638 | 0.200 |
Why?
|
Oxidoreductases, N-Demethylating | 2 | 2012 | 109 | 0.200 |
Why?
|
Pituitary Neoplasms | 1 | 2010 | 1325 | 0.190 |
Why?
|
Pregnancy Complications | 2 | 2011 | 2969 | 0.180 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2018 | 152 | 0.170 |
Why?
|
Hydrocortisone | 2 | 2012 | 1836 | 0.170 |
Why?
|
Heart Transplantation | 1 | 2013 | 3291 | 0.170 |
Why?
|
Histone Demethylases | 2 | 2012 | 322 | 0.170 |
Why?
|
Norepinephrine | 2 | 2013 | 900 | 0.160 |
Why?
|
Hypercalcemia | 2 | 2011 | 423 | 0.150 |
Why?
|
Double-Blind Method | 3 | 2017 | 12450 | 0.150 |
Why?
|
Insulin Resistance | 4 | 2017 | 3974 | 0.140 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 6320 | 0.140 |
Why?
|
Incretins | 1 | 2018 | 100 | 0.140 |
Why?
|
Blood Pressure | 6 | 2013 | 8537 | 0.140 |
Why?
|
Sulfonylurea Compounds | 1 | 2018 | 220 | 0.130 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15965 | 0.120 |
Why?
|
Syncope | 1 | 1997 | 430 | 0.120 |
Why?
|
Amino Acids, Aromatic | 1 | 2013 | 36 | 0.110 |
Why?
|
Amyloidosis | 2 | 1998 | 879 | 0.110 |
Why?
|
Mineralocorticoids | 1 | 2012 | 37 | 0.100 |
Why?
|
Surgical Procedures, Operative | 2 | 2014 | 1937 | 0.100 |
Why?
|
Hypertension, Renal | 1 | 2012 | 135 | 0.100 |
Why?
|
Middle Aged | 20 | 2018 | 223406 | 0.100 |
Why?
|
Diabetes Mellitus | 3 | 2015 | 5887 | 0.100 |
Why?
|
Inflammation | 1 | 2011 | 10863 | 0.090 |
Why?
|
Delayed-Action Preparations | 1 | 2015 | 969 | 0.090 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2012 | 167 | 0.090 |
Why?
|
Pharmacogenetics | 1 | 2015 | 677 | 0.090 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2013 | 269 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2018 | 16023 | 0.090 |
Why?
|
Polyuria | 1 | 2010 | 37 | 0.090 |
Why?
|
Epinephrine | 1 | 2013 | 795 | 0.090 |
Why?
|
Hemodynamics | 2 | 2011 | 4202 | 0.090 |
Why?
|
Hyperparathyroidism | 1 | 2011 | 339 | 0.090 |
Why?
|
Female | 25 | 2018 | 396926 | 0.080 |
Why?
|
Xerostomia | 1 | 2010 | 94 | 0.080 |
Why?
|
Diabetes Insipidus | 1 | 2010 | 144 | 0.080 |
Why?
|
Anorexia | 1 | 2010 | 152 | 0.080 |
Why?
|
Heart Failure | 1 | 2013 | 11859 | 0.080 |
Why?
|
Lipoproteins, HDL | 1 | 2013 | 682 | 0.080 |
Why?
|
Diet | 1 | 2007 | 8098 | 0.080 |
Why?
|
Cardiomyopathies | 2 | 1998 | 2056 | 0.080 |
Why?
|
Lymphatic Diseases | 1 | 2010 | 320 | 0.080 |
Why?
|
Glucose Tolerance Test | 3 | 2018 | 1181 | 0.080 |
Why?
|
Adult | 18 | 2018 | 223528 | 0.070 |
Why?
|
Coronary Stenosis | 1 | 2013 | 803 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2017 | 65408 | 0.070 |
Why?
|
PPAR gamma | 1 | 2010 | 487 | 0.070 |
Why?
|
Male | 21 | 2018 | 364761 | 0.070 |
Why?
|
Humans | 29 | 2022 | 768369 | 0.070 |
Why?
|
Low Back Pain | 2 | 2011 | 989 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6537 | 0.060 |
Why?
|
Triglycerides | 1 | 2013 | 2465 | 0.060 |
Why?
|
Environment | 1 | 2011 | 1126 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 13025 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2010 | 1841 | 0.060 |
Why?
|
Abdominal Pain | 1 | 2011 | 1070 | 0.060 |
Why?
|
Aged | 10 | 2018 | 171514 | 0.060 |
Why?
|
Glucocorticoids | 2 | 2012 | 2170 | 0.060 |
Why?
|
Normetanephrine | 1 | 2022 | 25 | 0.050 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2022 | 45 | 0.050 |
Why?
|
Sympatholytics | 1 | 2022 | 82 | 0.050 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21157 | 0.050 |
Why?
|
L-Selectin | 1 | 2022 | 212 | 0.050 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2930 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12096 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2022 | 251 | 0.050 |
Why?
|
Genetic Markers | 1 | 2007 | 2604 | 0.040 |
Why?
|
Prolactin | 1 | 2022 | 626 | 0.040 |
Why?
|
Toll-Like Receptor 2 | 1 | 2022 | 348 | 0.040 |
Why?
|
Phenotype | 5 | 2022 | 16712 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5803 | 0.040 |
Why?
|
Graft Rejection | 1 | 2013 | 4505 | 0.040 |
Why?
|
Cohort Studies | 3 | 2013 | 41782 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2022 | 380 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3854 | 0.040 |
Why?
|
Alleles | 3 | 2018 | 6880 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12875 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2010 | 2586 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 6995 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2022 | 586 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2012 | 3832 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2010 | 3472 | 0.040 |
Why?
|
Biopsy | 1 | 2010 | 6816 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13643 | 0.040 |
Why?
|
Syncope, Vasovagal | 1 | 1997 | 39 | 0.040 |
Why?
|
Body Mass Index | 2 | 2013 | 13030 | 0.040 |
Why?
|
Fasting | 2 | 2013 | 1608 | 0.040 |
Why?
|
Immunoglobulin Light Chains | 1 | 1998 | 288 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2012 | 1998 | 0.030 |
Why?
|
Risk Factors | 4 | 2018 | 74915 | 0.030 |
Why?
|
Glucagon | 1 | 2018 | 534 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 18047 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1852 | 0.030 |
Why?
|
Haplotypes | 2 | 2012 | 2723 | 0.030 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2018 | 367 | 0.030 |
Why?
|
Incidence | 1 | 2013 | 21552 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2017 | 59679 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8762 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2013 | 39429 | 0.030 |
Why?
|
Pregnancy | 2 | 2011 | 30179 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2010 | 22286 | 0.020 |
Why?
|
Potassium, Dietary | 1 | 2012 | 103 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2018 | 81835 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2013 | 450 | 0.020 |
Why?
|
Homeostasis | 2 | 2013 | 3351 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2022 | 3145 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 2013 | 521 | 0.020 |
Why?
|
Stress, Physiological | 1 | 1997 | 1409 | 0.020 |
Why?
|
Exercise Test | 1 | 1997 | 2186 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 1997 | 1568 | 0.020 |
Why?
|
Pregnancy Trimester, Third | 1 | 2011 | 583 | 0.020 |
Why?
|
Quantitative Trait, Heritable | 1 | 2011 | 540 | 0.020 |
Why?
|
Vomiting | 1 | 2011 | 655 | 0.020 |
Why?
|
Genetics, Medical | 1 | 2010 | 334 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 12813 | 0.020 |
Why?
|
Aldosterone | 1 | 2012 | 874 | 0.020 |
Why?
|
Genotype | 2 | 2012 | 13045 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15459 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2392 | 0.020 |
Why?
|
Edema | 1 | 2010 | 766 | 0.020 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2011 | 520 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2013 | 1898 | 0.010 |
Why?
|
Preoperative Care | 1 | 2013 | 2257 | 0.010 |
Why?
|
Electrocardiography | 1 | 1997 | 6410 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3615 | 0.010 |
Why?
|
Brain | 1 | 2010 | 27439 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36840 | 0.010 |
Why?
|
Lipids | 1 | 2013 | 3346 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8730 | 0.010 |
Why?
|
Skin Diseases | 1 | 2010 | 1099 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2742 | 0.010 |
Why?
|
Prospective Studies | 2 | 2018 | 54913 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4247 | 0.010 |
Why?
|
Exercise | 1 | 1997 | 5940 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10784 | 0.010 |
Why?
|
Prognosis | 2 | 1998 | 30031 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6521 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13323 | 0.010 |
Why?
|
Child | 1 | 2007 | 80856 | 0.010 |
Why?
|
DNA | 1 | 2012 | 7213 | 0.010 |
Why?
|
Macroglossia | 1 | 1998 | 12 | 0.010 |
Why?
|
Ecchymosis | 1 | 1998 | 32 | 0.010 |
Why?
|
Prednisolone | 1 | 1998 | 327 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7064 | 0.010 |
Why?
|
Colchicine | 1 | 1998 | 258 | 0.010 |
Why?
|
Melphalan | 1 | 1998 | 420 | 0.010 |
Why?
|
Young Adult | 2 | 2013 | 60038 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1998 | 578 | 0.010 |
Why?
|
Mice | 2 | 2012 | 82051 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18390 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2013 | 15879 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12771 | 0.010 |
Why?
|
Fatigue | 1 | 1998 | 1556 | 0.010 |
Why?
|
Animals | 2 | 2012 | 169424 | 0.010 |
Why?
|
Obesity | 1 | 2011 | 13065 | 0.010 |
Why?
|
Adolescent | 1 | 2013 | 89163 | 0.000 |
Why?
|
Echocardiography | 1 | 1998 | 5043 | 0.000 |
Why?
|
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_